(MSBI) Midland States Bancorp - Overview
Stock: Loans, Deposits, Leasing, Wealth
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 7.15% |
| Yield on Cost 5y | 7.65% |
| Yield CAGR 5y | 2.99% |
| Payout Consistency | 100.0% |
| Payout Ratio | 70.8% |
| Risk 5d forecast | |
|---|---|
| Volatility | 36.6% |
| Relative Tail Risk | -18.3% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.79 |
| Alpha | 20.80 |
| Character TTM | |
|---|---|
| Beta | 0.686 |
| Beta Downside | 0.647 |
| Drawdowns 3y | |
|---|---|
| Max DD | 44.34% |
| CAGR/Max DD | 0.06 |
Description: MSBI Midland States Bancorp December 29, 2025
Midland States Bancorp, Inc. (NASDAQ: MSBI) is a financial holding company that operates Midland States Bank, offering a broad suite of banking and wealth-management services to individuals, businesses, municipalities and other entities. Its product set spans commercial and residential loan portfolios-including commercial real-estate, construction, and land-development financing-as well as equipment leasing, depository accounts, and comprehensive trust and wealth-management solutions such as estate planning, investment management, and retirement-plan consulting. Founded in 1881 and headquartered in Effingham, Illinois, the firm reports under the “Regional Banks” sub-industry of the GICS classification.
As of Q3 2024, MSBI reported total assets of approximately $5.6 billion, a loan-to-deposit ratio of 73 %, and a Common Equity Tier 1 (CET1) capital ratio of 12.5 %, indicating solid capitalization relative to peers. The bank’s net interest margin expanded 8 % year-over-year, driven by a higher Fed funds rate that benefits its floating-rate loan book, while its commercial-real-estate loan exposure remains below the industry average at roughly 22 % of total loans-an important buffer amid ongoing CRE stress. Regional-bank earnings are also sensitive to small-business credit demand, which has been buoyed by recent consumer-spending resilience in the Midwest.
For a deeper dive into MSBI’s valuation metrics and peer comparison, see the ValueRay platform.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 31.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA 1.36 > 1.0 |
| NWC/Revenue: 379.0% < 20% (prev 265.7%; Δ 113.3% < -1%) |
| CFO/TA 0.04 > 3% & CFO 231.1m > Net Income 31.5m |
| Net Debt (-67.6m) to EBITDA (60.0m): -1.13 < 3 |
| Current Ratio: 27.46 > 1.5 & < 3 |
| Outstanding Shares: last quarter (21.9m) vs 12m ago 0.81% < -2% |
| Gross Margin: 64.93% > 18% (prev 0.59%; Δ 6434 % > 0.5%) |
| Asset Turnover: 5.99% > 50% (prev 6.20%; Δ -0.21% > 0%) |
| Interest Coverage Ratio: 0.41 > 6 (EBITDA TTM 60.0m / Interest Expense TTM 151.1m) |
Altman Z'' 1.81
| A: 0.24 (Total Current Assets 1.65b - Total Current Liabilities 60.2m) / Total Assets 6.51b |
| B: 0.02 (Retained Earnings 99.0m / Total Assets 6.51b) |
| C: 0.01 (EBIT TTM 61.7m / Avg Total Assets 7.02b) |
| D: 0.10 (Book Value of Equity 565.5m / Total Liabilities 5.95b) |
| Altman-Z'' Score: 1.81 = BBB |
What is the price of MSBI shares?
Over the past week, the price has changed by +4.95%, over one month by +11.79%, over three months by +53.21% and over the past year by +29.42%.
Is MSBI a buy, sell or hold?
- StrongBuy: 0
- Buy: 0
- Hold: 4
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the MSBI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 23.9 | -0.4% |
| Analysts Target Price | 23.9 | -0.4% |
| ValueRay Target Price | 28.3 | 17.9% |
MSBI Fundamental Data Overview February 02, 2026
P/B = 0.8565
P/EG = 2.2
Revenue TTM = 420.3m USD
EBIT TTM = 61.7m USD
EBITDA TTM = 60.0m USD
Long Term Debt = 340.0m USD (from longTermDebt, two quarters ago)
Short Term Debt = 60.2m USD (from shortTermDebt, last quarter)
Debt = 60.2m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -67.6m USD (from netDebt column, last quarter)
Enterprise Value = -1.10b USD (492.5m + Debt 60.2m - CCE 1.65b)
Interest Coverage Ratio = 0.41 (Ebit TTM 61.7m / Interest Expense TTM 151.1m)
EV/FCF = -4.85x (Enterprise Value -1.10b / FCF TTM 227.0m)
FCF Yield = -20.63% (FCF TTM 227.0m / Enterprise Value -1.10b)
FCF Margin = 54.01% (FCF TTM 227.0m / Revenue TTM 420.3m)
Net Margin = 7.49% (Net Income TTM 31.5m / Revenue TTM 420.3m)
Gross Margin = 64.93% ((Revenue TTM 420.3m - Cost of Revenue TTM 147.4m) / Revenue TTM)
Gross Margin QoQ = 71.93% (prev 50.33%)
Tobins Q-Ratio = -0.17 (set to none) (Enterprise Value -1.10b / Total Assets 6.51b)
Interest Expense / Debt = 55.49% (Interest Expense 33.4m / Debt 60.2m)
Taxrate = 21.0% (US default 21%)
NOPAT = 48.7m (EBIT 61.7m * (1 - 21.00%))
Current Ratio = 27.46 (Total Current Assets 1.65b / Total Current Liabilities 60.2m)
Debt / Equity = 0.11 (Debt 60.2m / totalStockholderEquity, last quarter 565.5m)
Debt / EBITDA = -1.13 (Net Debt -67.6m / EBITDA 60.0m)
Debt / FCF = -0.30 (Net Debt -67.6m / FCF TTM 227.0m)
Total Stockholder Equity = 616.9m (last 4 quarters mean from totalStockholderEquity)
RoA = 0.45% (Net Income 31.5m / Total Assets 6.51b)
RoE = 5.10% (Net Income TTM 31.5m / Total Stockholder Equity 616.9m)
RoCE = 6.45% (EBIT 61.7m / Capital Employed (Equity 616.9m + L.T.Debt 340.0m))
RoIC = 4.89% (NOPAT 48.7m / Invested Capital 997.2m)
WACC = 7.52% (E(492.5m)/V(552.6m) * Re(8.44%) + (debt cost/tax rate unavailable))
Discount Rate = 8.44% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.07%
[DCF Debug] Terminal Value 79.70% ; FCFF base≈200.1m ; Y1≈197.3m ; Y5≈203.1m
Fair Price DCF = 189.7 (EV 3.95b - Net Debt -67.6m = Equity 4.02b / Shares 21.2m; r=7.52% [WACC]; 5y FCF grow -2.24% → 2.90% )
EPS Correlation: -45.45 | EPS CAGR: -13.68% | SUE: 0.35 | # QB: 0
Revenue Correlation: 10.90 | Revenue CAGR: 11.99% | SUE: 1.15 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.61 | Chg30d=-0.020 | Revisions Net=+0 | Analysts=5
EPS current Year (2026-12-31): EPS=2.65 | Chg30d=-0.058 | Revisions Net=+0 | Growth EPS=+56.0% | Growth Revenue=-5.0%
EPS next Year (2027-12-31): EPS=2.75 | Chg30d=-0.046 | Revisions Net=+0 | Growth EPS=+3.6% | Growth Revenue=+2.1%